3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
12
Neoplasm Metastasis
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
HER2-positive Gastric Cancer
1
HER2-positive Breast Cancer
1
HER2-positive Advanced Gastric Cancer
1
HER2 Overexpression
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Interventions
Blood Specimen Collection
17
Pancreaticoduodenectomy
15
Surveys and Questionnaires
11
Endoscopic Ultrasound-Guided Fine Needle Aspiration
10
Observation
9
Biopsy
8
Specimen Handling
6
Pancreatectomy
6
Gemcitabine
6
Endosonography
6
Data Collection
6
Surgical Procedures, Operative
5
Magnetic Resonance Spectroscopy
5
Electroporation
5
Biopsy, Fine-Needle
5
Neoadjuvant Therapy
4
Magnetic Resonance Imaging
4
Liquid Biopsy
4
Interviews as Topic
4
Immunologic Techniques
4
Immunohistochemistry
4
Drug Therapy
4
folfirinox
3
Fluorouracil
3
Cholangiopancreatography, Endoscopic Retrograde
3
Albumin-Bound Paclitaxel
3
irinotecan sucrosofate
2
Taxes
2
Sulfonylurea Compounds
2
Secretin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Pancreatic Neoplasms
×
trastuzumab deruxtecan
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled